Clinical TrialsSearch results
Number of results: 214
Other
- Investigation of the Optimal Treatment Strategy for Atrial Fibrillation in Japan -The J-RHYTHM (Japanese Rhythm Management Trial for Atrial Fibrillation) Study-
- Atrial Fibrillation
- The J-RHYTHM Investigators
- 2005-09-08
Other
- A Randomized Study of Angiotensin II Type 1 Receptor Blocker vs Dihydropidine Ca Antagonist for Treatment of Paroxysmal Atrial Fibrillation in Patients with Hypertension
- Atrial Fibrillation with Hypertension
- The J-RHYTHM II Investigators
- 2006-07-10
Other
- Establishment of surveillance system for the longstanding ulcerative colitis patients Comparative study of efficacy for the targeted biopsy and the step biopsy
- Ulcerative colitis
- Teikyo University School of Medicine
- 2009-01-05
Other
- Japan colorectal tumor prevention study
- colorectal tumor
- Takayama Tetsuji
- 2019-03-20
Recruiting
- Phase II study of DCS-T
- gastric cancer
- Takayama Tetsuji
- 2019-03-22
Recruiting
- DOS study
- gastric cancer
- Takayama Tetsuji
- 2019-03-22
Completed
- Linked color image for SSA/P
- SSA/P
- Takayama Tetsuji
- 2019-03-04
Recruiting
- Evaluation of the efficacy of bioadhesive barrier-forming oral liquid gel (Episil) for prevention of oral mucositis
- Squamous cell carcinoma, adenosquamous carcinoma, basal cell carcinoma
- Takano HIdeyuki
- 2022-05-30
Other
- Efficacy of surgery vs. radiofrequency ablation on primary hepatocellular carcinoma: a prospective cohort study
- A case without informed consent for SURF-RCT among primary hepatocellular carcinoma cases with tumor foci numbering less than 3, each measuring 3 cm or less, Child-Pugh score of 7 or less, ages between 20 and 79 year, and indications for either surgical resection or radiofrequency ablation for the treatment
- Surgery vs. RFA (SURF) trial group
- 2009-04-01
Other
- Efficacy of surgery vs. radiofrequency ablation on primary hepatocellular carcinoma: a multicenter randomized controlled trial
- A primary hepatocellular carcinoma case with tumor foci numbering less than 3, each measuring 3 cm or less, Child-Pugh score of 7 or less, ages between 20 and 79 year, and indications for either surgical resection or radiofrequency ablation for the treatment
- Surgery vs. RFA (SURF) trial group
- 2009-04-01